A diverse group of experts collaborated on a set of recommendations for HDFN testing, prevention and treatment.
Most infants in the study with Rh-linked hemolytic disease were born with high iron levels that can persist for up to a year.
A newly found blood variant common in Indigenous Australians may raise HDFN risk by triggering anti-D antibodies.
Neonates who received IUTs after 34 weeks gestation were less likely to need exchange transfusions and less likely to be born ...
Lisa Shea, director of global patient advocacy and engagement for immunology at Johnson & Johnson, shows a colleague her e-poster at ISUOG 2025 in Cancún, Mexico. (Photo by Larry Luxner) A J&J ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback